Innovating Works

H2020

Cerrada
HORIZON-JU-IHI-2022-03-02
Patient-generated evidence to improve outcomes, support decision making, and accelerate innovation
ExpectedOutcome:Research and innovation (R&I) actions (projects) to be supported under this topic should aim to deliver results that contribute to all of the following expected outcomes for the use cases selected:
Sólo fondo perdido 0 €
Europeo
Esta convocatoria está cerrada Esta línea ya está cerrada por lo que no puedes aplicar. Cerró el pasado día 15-03-2023.
Se espera una próxima convocatoria para esta ayuda, aún no está clara la fecha exacta de inicio de convocatoria.
Por suerte, hemos conseguido la lista de proyectos financiados!
Presentación: Consorcio Consorcio: Esta ayuda está diseñada para aplicar a ella en formato consorcio..
Esta ayuda financia Proyectos:

ExpectedOutcome:Research and innovation (R&I) actions (projects) to be supported under this topic should aim to deliver results that contribute to all of the following expected outcomes for the use cases selected:

Decision makers have new methods for the integration of PROMs, PPI, and PREMs and other people-generated information into regulatory and health technology assessment (HTA) evaluation processes for integrated healthcare solutions.Patients of all ages have access to novel integrated healthcare solutions1 that are developed using structured patient input and better respond to their needs and preferences.Researchers have new methodological approaches to elicit and integrate patient preferences into the conception, development, and implementation of integrated healthcare solutions1.Researchers have wider access to interoperable, quality patient input and patient-generated data, respecting the FAIR (findable, accessible, interoperable, reusable) principles, facilitating the research and development of integrated healthcare solutions.Researchers are provided with new outcomes, outcome measures and the time horizon over which value should be assessed to devel... ver más

ExpectedOutcome:Research and innovation (R&I) actions (projects) to be supported under this topic should aim to deliver results that contribute to all of the following expected outcomes for the use cases selected:

Decision makers have new methods for the integration of PROMs, PPI, and PREMs and other people-generated information into regulatory and health technology assessment (HTA) evaluation processes for integrated healthcare solutions.Patients of all ages have access to novel integrated healthcare solutions1 that are developed using structured patient input and better respond to their needs and preferences.Researchers have new methodological approaches to elicit and integrate patient preferences into the conception, development, and implementation of integrated healthcare solutions1.Researchers have wider access to interoperable, quality patient input and patient-generated data, respecting the FAIR (findable, accessible, interoperable, reusable) principles, facilitating the research and development of integrated healthcare solutions.Researchers are provided with new outcomes, outcome measures and the time horizon over which value should be assessed to develop appropriate tools and methods for the collection and analysis of PROMs, PPI, and PREMs. 1 Integrated healthcare solutions are innovative solutions integrating various technologies, coupled with complementary tools and services.


Scope:The amount of health data generated by citizens themselves is rapidly increasing. Such data includes patient-reported outcome measures (PROMs), patient preference information (PPI), and patient-reported experience measures (PREMs), as well as other digital health data/digital biomarkers. While the potential for these data to be harnessed to improve individual healthcare is enormous, these data are often fragmented among multiple providers, so that neither the citizen, nor the healthcare ecosystem have a comprehensive overview, and therefore it is very challenging to fully use these data to provide reliable evidence for decision-makers, and to improve health outcomes.

Research and innovation (R&I) actions to be supported under this topic will aim to address this challenge by:

Developing a framework to integrate patient input and patient-generated data for use in decision making (regulatory, health economic evaluation, reimbursement, healthcare programme design, tailored prescription of therapies, and technology development), benefit-risk evaluation and value assessment of integrated healthcare solutions.1 Applicants should build on existing frameworks where appropriate and appropriately address ethics considerations.Implement several use cases to support and demonstrate the use of the framework, focusing on using patient input and patient-generated evidence to address challenges that are not adequately addressed by other initiatives. These use cases should demonstrate the value of using patient input (PROMs, PPI, PREMs) and patient generated data (digital health data/digital biomarkers) along the healthcare continuum, including showcasing improvements to data interoperability, healthcare workflows and processes, disease prevention, and care, including home-based care. These use cases should also act as examples of best practice for future use of the framework.Facilitating multi-stakeholder access to patient inputs and patient-generated health data such that actionable harmonised data can be used for quality decision making.Comparing/contrasting the properties of the three types of patient input (PROMs, PPI, PREMs), identify differences and opportunities for integrated/complementary use.Developing an approach or approaches to integrating PROMs, PPI, and PREMs data into the design of core outcomes sets, end-to-end patient treatment pathways, clinical decision support systems, and treatment guidelines. The core outcome sets used within the project should be made available more widely where possible. Applicants are expected to seek engagement with regulators where relevant (e.g. through the EMA Innovation Task Force, scientific advice) and consider allocating appropriate resources to explore synergies with other relevant initiatives and projects.


Expected Impact:The following impacts are expected:

Enable the added value of people-centred integrated healthcare solutions1 to be assessed according to criteria that matter to patients and citizens, using patient-reported outcome measures (PROMs), patient preference information (PPI), and patient-reported experience measures (PREMs).Facilitate the development and implementation of integrated healthcare solutions based on patient input including PROMs, PPI, and PREMs. These solutions should better respond to the needs and preferences of patients and citizens and support an inclusive approach.Enable the smart use of patient input and patient-generated evidence to facilitate the faster market entry of patient-centric and cost-effective advanced integrated healthcare solutions1, and also spur further innovation by improving return on research and innovation investments.Use patient input gathered via m-health, e-health and other technologies to gain improved insights into the real-life behaviour of, and challenges faced by, patients of all ages with complex, chronic diseases and co-morbidities. 1 Integrated healthcare solutions are innovative solutions integrating various technologies, coupled with complementary tools and services.


ver menos

Temáticas Obligatorias del proyecto: Temática principal:

Características del consorcio

Ámbito Europeo : La ayuda es de ámbito europeo, puede aplicar a esta linea cualquier empresa que forme parte de la Comunidad Europea.
Tipo y tamaño de organizaciones: El diseño de consorcio necesario para la tramitación de esta ayuda necesita de:
Empresas Micro, Pequeña, Mediana, Grande
Centros Tecnológicos
Universidades
Organismos públicos

Características del Proyecto

Requisitos de diseño: Duración: Requisitos técnicos: ExpectedOutcome:Research and innovation (R&I) actions (projects) to be supported under this topic should aim to deliver results that contribute to all of the following expected outcomes for the use cases selected: ¿Quieres ejemplos? Puedes consultar aquí los últimos proyectos conocidos financiados por esta línea, sus tecnologías, sus presupuestos y sus compañías.
Capítulos financiables: Los capítulos de gastos financiables para esta línea son:
Madurez tecnológica: La tramitación de esta ayuda requiere de un nivel tecnológico mínimo en el proyecto de TRL 4:. Es el primer paso para determinar si los componentes individuales funcionarán juntos como un sistema en un entorno de laboratorio. Es un sistema de baja fidelidad para demostrar la funcionalidad básica y se definen las predicciones de rendimiento asociadas en relación con el entorno operativo final. leer más.
TRL esperado:

Características de la financiación

Intensidad de la ayuda: Sólo fondo perdido + info
Fondo perdido:
0% 25% 50% 75% 100%
The funding rate for RIA projects is 100 % of the eligible costs for all types of organizations.
Condiciones: No existe condiciones financieras para el beneficiario.

Información adicional de la convocatoria

Efecto incentivador: Esta ayuda no tiene efecto incentivador. + info.
Respuesta Organismo: Se calcula que aproximadamente, la respuesta del organismo una vez tramitada la ayuda es de:
Meses de respuesta:
Muy Competitiva:
No Competitiva Competitiva Muy Competitiva
No conocemos el presupuesto total de la línea pero en los últimos 6 meses la línea ha concecido
Total concedido en los últimos 6 meses.
Minimis: Esta línea de financiación NO considera una “ayuda de minimis”. Puedes consultar la normativa aquí.

Otras ventajas

Sello PYME: Tramitar esta ayuda con éxito permite conseguir el sello de calidad de “sello pyme innovadora”. Que permite ciertas ventajas fiscales.